BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 34.59M | 37.65M | 47.48M | 60.05M | 67.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.59M | 37.65M | 47.48M | 60.05M | 67.98M |
| Cost of Revenue | 6.94M | 4.57M | 3.04M | 6.28M | 9.31M |
| Gross Profit | 27.65M | 33.08M | 44.44M | 53.77M | 58.68M |
| SG&A Expenses | 44.34M | 40.67M | 37.82M | 31.45M | 29.99M |
| Depreciation & Amortization | 1.33M | 705.80K | 219.40K | 226.30K | 222.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.92M | 52.47M | 48.17M | 44.83M | 44.93M |
| Operating Income | -23.34M | -14.82M | -689.10K | 15.22M | 23.06M |
| Income Before Tax | -23.64M | -14.49M | -389.70K | 15.27M | 22.95M |
| Income Tax Expenses | 4.65M | 4.82M | 6.19M | -4.08M | -2.46M |
| Earnings from Continuing Operations | -28.29 | -19.31 | -6.58 | 19.35 | 25.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.29M | -19.31M | -6.58M | 19.35M | 25.41M |
| EBIT | -23.34M | -14.82M | -689.10K | 15.22M | 23.06M |
| EBITDA | -22.00M | -14.12M | -469.70K | 15.44M | 23.28M |
| EPS Basic | -1.67 | -1.16 | -0.40 | 1.17 | 1.54 |
| Normalized Basic EPS | -0.85 | -0.54 | -0.02 | 0.57 | 0.87 |
| EPS Diluted | -1.69 | -1.17 | -0.50 | 0.78 | 1.07 |
| Normalized Diluted EPS | -0.87 | -0.56 | -0.11 | 0.38 | 0.61 |
| Average Basic Shares Outstanding | 67.53M | 66.91M | 66.73M | 66.67M | 66.24M |
| Average Diluted Shares Outstanding | 74.01M | 80.11M | 89.51M | 97.39M | 95.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |